Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer

Por Müller, Volkmar, Clemens, Michael, Jassem, Jacek, Al-Sakaff, Nedal, Auclair, Petra, Nüesch, Eveline, Holloway, Debbie, Shing, Mona, Bang, Yung-Jue
Publicado no BMC Cancer (2018)